Common Dosage
Topical (1-3%) or Injectable (1mg-2mg daily)
Category
Skin & Hair
- Collagen production
- Wound healing
- Hair growth
GHK-Cu (glycyl-L-histidyl-L-lysine:copper) was first identified in 1973 by Loren Pickart, who discovered it in human plasma albumin as the fraction responsible for promoting liver cell regeneration. Subsequent research revealed it declines significantly with age — from approximately 200ng/ml at age 20 to 80ng/ml at 60. Pickart's decades-long career was devoted to characterizing GHK-Cu's remarkably broad biological activity, from skin regeneration to gene expression regulation. It has since become one of the most researched cosmetic peptides in the skincare industry.
GHK-Cu works through multiple mechanisms simultaneously. It activates collagen synthesis by stimulating fibroblast production of collagen I, III, and IV. It promotes angiogenesis for improved wound vascularization. It modulates gene expression broadly — studies have identified GHK-Cu as upregulating over 30 anti-aging genes while downregulating inflammatory and disease-related genes. It also chelates copper and delivers it to enzymes requiring copper as a cofactor, supporting normal tissue metalloenzyme function.
- Skin aging reversal — wrinkle reduction and elasticity improvement
- Wound healing acceleration including chronic wounds
- Hair follicle stimulation and growth promotion
- Anti-inflammatory skin conditions (eczema, psoriasis research)
- Post-procedure skin recovery
- Collagen induction and anti-aging protocols
- Lung and liver tissue protection
Clinical Skin Studies
Multiple double-blind cosmetic clinical studies have demonstrated measurable wrinkle reduction, improved skin density, and enhanced skin elasticity with topical GHK-Cu-containing formulations over 8–12 weeks. It is one of the few peptides with a meaningful clinical evidence base in skin aging.
Hair Loss Reversal
Studies comparing GHK-Cu to minoxidil in androgenetic alopecia have shown comparable or superior effects in some parameters, with GHK-Cu increasing hair density, thickness, and follicle size. The mechanism involves miniaturization reversal through anti-DHT gene expression effects and improved follicle blood supply.
Injectable Systemic Effects
Injectable GHK-Cu (1–2mg subcutaneous) is reported by users and integrative practitioners to produce systemic effects beyond skin — including improved energy, faster exercise recovery, and reduced systemic inflammation — consistent with its documented gene expression regulatory activity.
- Injection site pain is consistently reported as significant — topical routes are often preferred for skin applications
- Copper accumulation is a theoretical concern with heavy or prolonged injectable use — monitoring zinc (which competes with copper for absorption) is advisable
- Topical cosmetic products often contain inadequate concentrations relative to studied effective doses — independent verification of concentration is important
- Systemic injections have limited clinical evidence compared to topical applications
- Injection site pain (common)
- Zinc depletion
Injury & Surgery Recovery
Protocols designed to accelerate tissue repair, reduce inflammation, and improve healing outcomes for tendons, ligaments, and muscles.
Anti-Aging & Longevity
Strategies to improve skin elasticity, sleep quality, energy levels, and cellular health.
Skin & Hair Health
Targeted treatments for skin elasticity, wound healing, and hair restoration.